• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

La Trobe’s infection-busting discovery

Bioengineer by Bioengineer
May 17, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A team of scientists from Melbourne's La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases.

The scientific discovery, published in the prestigious journal Nature Communications, could lead to the development of a new class of antibiotics and meet the challenge of rising antibiotic resistance.

Dr Mark Hulett and Dr Marc Kvansakul from the La Trobe Institute for Molecular Science said their team had demonstrated the peptide NaD1 found in the flowers of the ornamental tobacco plant Nicotiana alata has infection-busting qualities.

"Infectious diseases are a major global health problem, accounting for more than one in eight deaths and mortality rates are predicted to skyrocket over the next 30 years," Dr Hulett said.

"Antibiotic resistance at the current rate will eventually lead to the exhaustion of effective long-term drug options. It's imperative we develop new antibiotic treatments."

Using the power of the Australian Synchrotron, the team led by Dr Hulett and Dr Kvansakul have shown in atomic detail how the tobacco plant peptide can target and destroy the micro-organism responsible for a dangerous fungal infection.

The peptide perforates the parachute-like outer layer of Candida albicans cells, ripping them apart and causing them to explode and die.

"They act in a different way to existing antibiotics and allow us to explore new ways of fighting infections.

"It's an exciting discovery that could be harnessed to develop a new class of life-saving antimicrobial therapy to treat a range of infectious diseases, including multidrug-resistant golden staph, and viral infections such as HIV, Zika virus, Dengue and Murray River Encephalitis."

In 2014, Dr Hulett and Dr Kvansakul found NaD1 could also be effective in killing cancer cells.

Background

Candida albicans is responsible for life-threatening infections in immune-compromised patients, including those diagnosed with cancer and transplant recipients. There are limited effective antibiotics available to treat the infection.

Nicotiana alata flowers naturally produce potent antifungal molecules for protection against disease. The plant is related, but different, to tobacco plants grown for commercial use.

###

The research was funded by The Australian Research Council and La Trobe University.

Media Contact Anastasia Salamastrakis +61 3 428 195 464

Media Contact

Anastasia Salamastrakis
[email protected]
61-342-819-5464

http://www.latrobe.edu.au

http://www.latrobe.edu.au/news/articles/2018/release/la-trobes-infection-busting-discovery

Related Journal Article

http://dx.doi.org/10.1038/s41467-018-04434-y

Share12Tweet7Share2ShareShareShare1

Related Posts

Occasional Heavy Drinking Could Triple Risk of Liver Damage, Study Finds

April 2, 2026

Rethinking Obesity Diagnosis Beyond BMI Could Postpone Critical Treatment, Study Finds

April 2, 2026

MYC-Driven USP10 Stabilizes SOX4, Fuels Leukemia

April 2, 2026

Parkinson’s Mutations Cause Lipid Defects, Rescued

April 2, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Occasional Heavy Drinking Could Triple Risk of Liver Damage, Study Finds

Rethinking Obesity Diagnosis Beyond BMI Could Postpone Critical Treatment, Study Finds

Broadening America’s Involvement in Fusion Energy Projects in France and Japan

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.